{{text}}
Global rank | 768 299 |
---|---|
Daily visitors | - |
Daily pageviews | - |
Pageviews per user | 0 |
Rating | |
---|---|
Latest check |
Astrazenecaclinicaltrials.com is tracked by us since December, 2016. Over the time it has been ranked as high as 5 379 899 in the world. It was owned by several entities, from DOMAINS administration of AstraZeneca AB to REDACTED FOR PRIVACY of AstraZeneca AB, it was hosted by Corporation Service Company and CloudFlare Inc.. While CSC Corporate Domains Inc. was its first registrar, now it is moved to Nom-iq Ltd. dba COM LAUDE.
Astrazenecaclinicaltrials has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Astrazenecaclinicaltrials.com is poorly ‘socialized’ in respect to any social network. According to MyWot and Google safe browsing analytics, Astrazenecaclinicaltrials.com is quite a safe domain with no visitor reviews.
It seems that traffic on this site is too low to be displayed, sorry.
It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.
Similar Traffic Stats
rank | visitors / pageviews |
---|---|
768297 |
547 / 547 |
768298 |
547 / 547 |
768299 |
- / - |
Astrazenecaclinicaltrials.com has no subdomains with considerable traffic.
Astrazenecaclinicaltrials.com is not yet effective in its SEO tactics: it has Google PR 0. It may also be penalized or lacking valuable inbound links.
Ranks
0
Google PR
-
Yandex CY
Homepage Top Backlinks | PR |
---|---|
astrazeneca.com | 7 |
medimmune.com | 6 |
astrazeneca.co.uk | 6 |
astrazeneca.es | 6 |
astrazeneca.fr | 6 |
Metadata Updates
{{text}}
Top Keywords | % of search traffic |
---|---|
astrazeneca | 53.51% |
astrazeneca clinical trials | 13.40% |
asztra zeneca clinical trials | 8.17% |
astra zeneca | 6.51% |
astrazeneca - capri trial | 3.42% |
Astrazenecaclinicaltrials.com domain is owned by REDACTED FOR PRIVACY AstraZeneca AB and its registration expires in 1 year.
General
REDACTED FOR PRIVACY AstraZeneca AB
Owner since March 24, 2024
1 year left
Expires on December 01, 2025
19 years old
Created on December 01, 2004
23 days ago
Changed at May 13, 2024
Registrar and Status
Registar | Nom-iq Ltd. dba COM LAUDE |
Status |
clientDeleteProhibited clientTransferProhibited clientUpdateProhibited |
In Other TLDs
No data
Astrazenecaclinicaltrials.com has 0% of its total traffic coming from social networks (in last 3 months) and the most active engagement is detected in Facebook (4 shares)
Social Metrics
0%
of total traffic in last 3 months is social
Astrazenecaclinicaltrials.com is hosted by CloudFlare, Inc.
IP Whois
CloudFlare, Inc.
104.18.14.236
IP address
Server technologies
No data
DNS Records
Host
astrazenecaclinicaltrials.com
Value
3.132.65.30
ttl
47
Host
astrazenecaclinicaltrials.com
Value
3.23.116.34
ttl
47
Host
astrazenecaclinicaltrials.com
Value
3.132.48.92
ttl
47
Host
astrazenecaclinicaltrials.com
Value
ttl
47
Host
astrazenecaclinicaltrials.com
Value
ttl
47
Host
astrazenecaclinicaltrials.com
Value
ttl
47
Host
astrazenecaclinicaltrials.com
Value
sesosn01.astrazeneca.com
ttl
300
PRI
30
Host
astrazenecaclinicaltrials.com
Value
dns2.comlaude-dns.net
ttl
300
Host
astrazenecaclinicaltrials.com
Value
dns3.comlaude-dns.co.uk
ttl
300
Host
astrazenecaclinicaltrials.com
Value
dns4.comlaude-dns.eu
ttl
300
Host
astrazenecaclinicaltrials.com
Value
dns1.comlaude-dns.com
ttl
300
Host
astrazenecaclinicaltrials.com
Value
Mname: dns1.comlaude-dns.com
Rname: dnstech.comlaude.com
Serial: 1707329166
Refresh: 43200
Retry: 7200
Expire: 1209600
Minimum-ttl: 3600
ttl
300
Host
astrazenecaclinicaltrials.com
Value
Txt: v=spf1 -all
ttl
300
Nameservers
Safety status of Astrazenecaclinicaltrials.com is described as follows: MyWOT reports its overall reputation as good and Google Safe Browsing reports its status as safe.
MyWOT
Overall reputation | Good |
---|---|
Trustworthiness | Good |
Privacy | Good |
Child safety | Unknown |
Google Safe Browsing
Website status | Safe |
---|---|
Status | ok |
User reviews
Reputation | Unknown |
---|
0
Positive0
NegativeRecently analyzed sites